McKesson Corporation
Price: 790.44Company and Business Model
McKesson Corporation is a leading healthcare services and information technology company. It primarily operates in the distribution of pharmaceuticals and provides healthcare management solutions. Major business segments include pharmaceutical distribution, medical-surgical distribution, and healthcare technology. The company's main revenue sources are from the sale of prescription drugs, medical supplies, and related services to healthcare providers, pharmacies, and hospitals.
Investment Profile
The investment profile of McKesson Corporation is more aligned with value investors, given its stable revenue growth and modest dividend yield. The stock may appeal to those seeking a balanced approach, as it offers potential for capital appreciation alongside income generation. However, the higher risk factors suggest caution for investors.
Fundamental metrics (experimental)
- EPS (TTM) — earnings per share for the last 12 months, $
- 38.64 OK
- Revenue QoQ — quarter-over-quarter revenue growth
- -9.3% ↓
- EPS surprise
- 1.9% in line
- 20d volatility
- 1.4% stable
- Dividend yield
- 0.4% low last ex-date: 2026-06-01
Track in portfolio
Price chart
| Date | Before | After | Reason |
|---|---|---|---|
| 2026-06-09 02:45 | Buy | Sell | Weak fundamentals and negative momentum raise concerns. |
| 2026-06-05 02:42 | Hold | Buy | Mixed performance; cautious outlook amid market pressures. |
| 2026-06-01 02:44 | Sell | Hold | Weak momentum and high risk overshadow potential upside. |
| Date | Analyst | Action | Target | Price Then |
|---|---|---|---|---|
| 2026-05-08 14:52 | UBS | Target Raised | 1000 → 1050 | 744.46 |
| 2026-05-08 12:53 | Deutsche Bank | Target Lowered | 973 → 875 | 763.9 |
| 2026-03-05 15:28 | Raymond James | Update | — → 970 | 930.31 |
Nothing yet